Myovant Sciences Stock Current Ratio
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
Myovant Sciences fundamentals help investors to digest information that contributes to Myovant Sciences' financial success or failures. It also enables traders to predict the movement of Myovant Stock. The fundamental analysis module provides a way to measure Myovant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myovant Sciences stock.
Myovant |
Myovant Sciences Company Current Ratio Analysis
Myovant Sciences' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Myovant Sciences Current Ratio | 1.83 X |
Most of Myovant Sciences' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myovant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Myovant Sciences has a Current Ratio of 1.83 times. This is 37.11% lower than that of the Biotechnology sector and 73.86% lower than that of the Health Care industry. The current ratio for all United States stocks is 15.28% higher than that of the company.
Myovant Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myovant Sciences' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Myovant Sciences could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics of similar companies.Myovant Sciences is currently under evaluation in current ratio category among related companies.
Myovant Fundamentals
| Return On Asset | -0.18 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.39) % | |||
| Current Valuation | 2.6 B | |||
| Shares Outstanding | 97.26 M | |||
| Shares Owned By Insiders | 48.61 % | |||
| Shares Owned By Institutions | 56.21 % | |||
| Number Of Shares Shorted | 8.39 M | |||
| Price To Earning | (8.56) X | |||
| Price To Book | 70.01 X | |||
| Price To Sales | 7.80 X | |||
| Revenue | 230.97 M | |||
| Gross Profit | 72.02 M | |||
| EBITDA | (183.89 M) | |||
| Net Income | (205.98 M) | |||
| Cash And Equivalents | 371.29 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 358.7 M | |||
| Debt To Equity | 138.60 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | (5.75) X | |||
| Cash Flow From Operations | (268.56 M) | |||
| Short Ratio | 11.21 X | |||
| Earnings Per Share | (1.92) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 579 | |||
| Beta | 2.15 | |||
| Market Capitalization | 2.62 B | |||
| Total Asset | 520.01 M | |||
| Retained Earnings | (811.83 M) | |||
| Working Capital | 123.03 M | |||
| Current Asset | 150.17 M | |||
| Current Liabilities | 27.14 M | |||
| Z Score | 2.8 | |||
| Net Asset | 520.01 M |
About Myovant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myovant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myovant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myovant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |